Annexon's lead investigational therapy, tanruprubart, is a first-of-its kind selective, targeted and rapid-acting agent designed to reduce inflammation and nerve damage by stopping C1q activity in the ...

A neurologist has sent a patient for nerve conduction studies (NCS ... NCS are only part of a complete peripheral neurophysiological examination (PNE) and are frequently accompanied by a needle ...

Whereas the symptoms of Type 1 come on rather suddenly, Type 2 is often characterised by a slow and gradual development, causing delays in diagnosis. “For both types of diabetes, clean and healthy ...